ARHGAP10 and lung cancer: In non‐small cell lung cancer, emerging evidence has indicated that the antitumor mechanism of ARHGAP10 directly mediated the epithelial‐mesenchymal transition process via the PI3K/Akt/GSK3β pathway.17